Therapeutic compounds

• 收藏
• 分享

专利权人:

Inc.;Gilead Sciences

发明人:

Ramanathan, Srinivasan

申请号：

AU2013204727

公开号：

AU2013204727A1

申请日:

2013.02.01

申请国别(地区):

AU

年份:

2013

代理人:

摘要：

#$%^&*AU2013204727A120130822.pdf#####-92 ABSTRACT The use of the henifurmarate form of {9-[(R)-2-[[(S)-[[(S)-1(isopropoxvcarbonyl)ethyllamino]phenoxvphosphinvl]methoxy]propyl]adenine } (tenofovir alafenamide hemifumarate) in combination with cobicistat is disclosed In addition, the combination of tenofovir alafenamide hemifiumarate, cobicistat, entricitabine, and elvitegravir, and the combination of tenofovir alafenamide hemifumarate, cobicistat, emtricitabine, and darunavir, are disclosed. FCHJS WS 8599433vi.doc

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/